Dr. Eric Olsen
And finally this week we have news from newly launched Syros Pharmaceuticals who has appointed Dr. Eric Olsen as Chief Scientific Officer.
Olson has over 25 years of experience in the industry, most recently as Research Vice President for respiratory diseases at Vertex Pharmaceuticals.
Dr. Nancy Simonian, Syros’s CEO said of the new CSO: “The combination of his deep scientific expertise, his understanding for translating science into drugs that actually help people, and his experience creating real value for shareholders is extraordinary. It fits perfectly with Syros' mission.”